Literature DB >> 13784380

Experimental infections with Coxsackie viruses. I. Studies on virulence and pathogenesis in Cynomolgus monkeys.

H A WENNER, T Y LOU, P S KAMITSUKA.   

Abstract

Entities:  

Keywords:  COXSACKIE VIRUSES/infection

Mesh：

Year:  1961        PMID： 13784380

Source DB:  PubMed          Journal:  Arch Gesamte Virusforsch        ISSN： 0003-9012


× No keyword cloud information.
  20 in total

1.  Pericarditis caused by Coxsackie virus B.

Authors:  H KAGAN; H BERNKOPF
Journal:  Ann Paediatr       Date:  1957-07

2.  [Isolation and investigation of the IV immunological type of poliomyelitis virus].

Authors:  M P CHUMAKOV; M K VOROSHILOVA; V I ZHEVANDROVA; L L MIRONOVA; F G ITSELIS; Ia ROBINZON
Journal:  Vopr Virusol       Date:  1956 Jan-Feb

3.  Monolayer tissue cultures. I. Preparation and standardization of suspensions of trypsin-dispersed monkey kidney cells.

Authors:  J S YOUNGNER
Journal:  Proc Soc Exp Biol Med       Date:  1954-02

4.  Reproducible oral infection rates in monkeys with the Mahoney strain (Type 1) of poliomyelitis virus.

Authors:  L P GEBHARDT; J G BACHTOLD
Journal:  Proc Soc Exp Biol Med       Date:  1953 Aug-Sep

5.  A virus isolated from patients diagnosed as non-paralytic poliomyelitis or aseptic meningitis.

Authors:  J L MELNICK; E W SHAW; E C CURNEN
Journal:  Proc Soc Exp Biol Med       Date:  1949-07

6.  Herpangina; etiological studies of a specific infectious disease.

Authors:  R J HUEBNER; R M COLE; E A BEEMAN; J A BELL; J H PEERS
Journal:  J Am Med Assoc       Date:  1951-03-03

7.  Neuropathogenicity of group A Coxsackie viruses.

Authors:  G DALLDORF
Journal:  J Exp Med       Date:  1957-07-01       Impact factor: 14.307

8.  Passage of Coxsackie virus (Connecticut-5 strain) in adult mice with production of pancreatic disease.

Authors:  A M PAPPENHEIMER; L J KUNZ; S RICHARDSON
Journal:  J Exp Med       Date:  1951-07-01       Impact factor: 14.307

9.  The sparing effect of Coxsackie virus infection on experimental poliomyelitis.

Authors:  G DALLDORF
Journal:  J Exp Med       Date:  1951-07-01       Impact factor: 14.307

10.  Quantitative studies of the virus-host relationship in chimpanzees after inapparent infection with Coxsackie viruses. I. The virus carrier state and the development of neutralizing antibodies.

Authors:  J L MELNICK; A S KAPLAN
Journal:  J Exp Med       Date:  1953-03       Impact factor: 14.307
View more
  8 in total

1.  [ON THE NEUROPATHOGENICITY OF COXSACKIE A-7 VIRUS].

Authors:  H PETTE; K FISCHER; L VALENCIANO; K SCHELL; J BERENGUER
Journal:  Arch Gesamte Virusforsch       Date:  1963-10-07

2.  [Epidemiology of ECHO virus infections].

Authors:  A GIOVANARDI; F BERGAMINI
Journal:  Arch Gesamte Virusforsch       Date:  1963

3.  Experimental infections with Coxackie viruses. II. Myocarditis in Cynomolgus monkeys infected with B 4 virus.

Authors:  T Y LOU; H A WENNER; P S KAMITSUKA
Journal:  Arch Gesamte Virusforsch       Date:  1961

4.  Pathology of murine cytomegalovirus infection in newborn mice. Muscle, heart, and brown fat lesions.

Authors:  G Lussier
Journal:  Can J Comp Med       Date:  1974-04

Review 5.  Viral myocarditis. A review.

Authors:  J F Woodruff
Journal:  Am J Pathol       Date:  1980-11       Impact factor: 4.307

6.  Coxsackie A-7 virus infections of rodents.

Authors:  N R Grist; G B Roberts
Journal:  Arch Gesamte Virusforsch       Date:  1966

7.  Characterizing the picornavirus landscape among synanthropic nonhuman primates in Bangladesh, 2007 to 2008.

Authors:  M Steven Oberste; Mohammed M Feeroz; Kaija Maher; W Allan Nix; Gregory A Engel; Kamrul M Hasan; Sajeda Begum; Gunwha Oh; Anwarul H Chowdhury; Mark A Pallansch; Lisa Jones-Engel
Journal:  J Virol       Date:  2012-10-24       Impact factor: 5.103

8.  Naturally acquired picornavirus infections in primates at the Dhaka zoo.

Authors:  M Steven Oberste; Mohammed M Feeroz; Kaija Maher; W Allan Nix; Gregory A Engel; Sajeda Begum; Kamrul M Hasan; Gunwha Oh; Mark A Pallansch; Lisa Jones-Engel
Journal:  J Virol       Date:  2012-10-24       Impact factor: 5.103
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.